The historic Trans-Pacific Partnership negotiations finalized today could affect the cost of health care in significant ways.
The latest stabbing of a pharmacist has renewed calls for tougher sentencing and increased policing to protect pharmacists.
The FDA has approved Juviderm Ultra XC for lip augmentation in adults ages 21 or older.
Hot button health care issues dominate many of the presidential contenders’ political platforms.
Summer was a busy season for FDA drug warnings.
A pharmacist in Nebraska has pleaded guilty to what is possibly the largest case of Medicaid fraud in the state.
Dual antiplatelet therapy (DAPT) with aspirin and another antiplatelet agent such as clopidogrel, prasugrel, or ticagrelor is the go-to preventive therapy for patients who have experienced certain cardiovascular events.
This weekly video program highlights the latest in pharmacy news, product news, and more.
As Hurricane Joaquin blasts the Bahamas, many have feared that the storm would travel north to the East Coast.
More children than previously thought have trouble sleeping, and a third of them are given medication for it.
The FDA is considering approval for an intranasal formulation of the opioid overdose antidote naloxone (Narcan).
Approximately 65% of individuals undergoing chemotherapy will experience chemotherapy-induced hair loss, which is usually temporary and completely reversible when therapy ends.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Strategic Alliance Partners